- Home
- JAGX vs GLMD Comparison
JAGX vs GLMD Comparison
Compare JAGX & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- GLMD
- Stock Information
- Founded
- JAGX 2013
- GLMD 2000
- Country
- JAGX United States
- GLMD Israel
- Employees
- JAGX N/A
- GLMD N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- JAGX Health Care
- GLMD Health Care
- Exchange
- JAGX Nasdaq
- GLMD Nasdaq
- Market Cap
- JAGX 3.5M
- GLMD 4.1M
- IPO Year
- JAGX N/A
- GLMD 2014
- Fundamental
- Price
- JAGX $2.39
- GLMD $2.09
- Analyst Decision
- JAGX Strong Buy
- GLMD Hold
- Analyst Count
- JAGX 1
- GLMD 1
- Target Price
- JAGX $60.00
- GLMD N/A
- AVG Volume (30 Days)
- JAGX 98.7K
- GLMD 410.0K
- Earning Date
- JAGX 08-12-2025
- GLMD 08-27-2025
- Dividend Yield
- JAGX N/A
- GLMD N/A
- EPS Growth
- JAGX N/A
- GLMD N/A
- EPS
- JAGX N/A
- GLMD N/A
- Revenue
- JAGX $11,552,000.00
- GLMD N/A
- Revenue This Year
- JAGX $22.41
- GLMD N/A
- Revenue Next Year
- JAGX $30.00
- GLMD N/A
- P/E Ratio
- JAGX N/A
- GLMD N/A
- Revenue Growth
- JAGX 13.93
- GLMD N/A
- 52 Week Low
- JAGX $2.28
- GLMD $1.15
- 52 Week High
- JAGX $110.75
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- JAGX 29.08
- GLMD 63.64
- Support Level
- JAGX $2.53
- GLMD $1.87
- Resistance Level
- JAGX $2.79
- GLMD $2.22
- Average True Range (ATR)
- JAGX 0.20
- GLMD 0.14
- MACD
- JAGX 0.12
- GLMD 0.01
- Stochastic Oscillator
- JAGX 8.96
- GLMD 72.92
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.